|
| Number of patients | Eradication rate |
| Total | 65 | 93.8% |
| Mean age (y): 11.82 ± 3.18 |
|
|
| Range (y): 4.92 - 19.25 |
|
|
| CAM: S, AMPC: S, MNZ: S | 27 | 92.6% |
| (PPI + AMPC + CAM therapy) |
|
|
| CAM: R, AMPC: S, MNZ: S | 31 | 97.0% |
| (PPI + AMPC + MNZ therapy) |
|
|
| CAM: R, AMPC: S, MNZ: R | 1 | 100% |
| (PPI + AMPC + LVFX therapy) |
|
|
| CAM: R, AMPC: R, MNZ: S | 3 | 75.0% |
| (PPI + MINO + MNZ therapy) |
|
|